
Life sciences equity analyst with a passion for biotech and healthcare investing. Founder of NDF Research and co-founder of Pitt Street Research, known for turning complex science and technology into clear, investable ideas
https://pittstreetresearch.com/A newly listed Canadian explorer is betting it can turn a large, near-surface gold find into something bigger by drilling beyond the old boundaries and tightening up what’s already known. With good access, straightforward processing, and hints of copper and silver on the same ground, the next round of results could change how the market views the project—though delays, funding needs, and gold prices still matter.Read more

Unicycive’s kidney drug aims to make life easier for dialysis patients by cutting down the daily pill burden, and it could finally reach the market after a manufacturing setback. The next big moment is the regulator’s decision, but the same manufacturing and rollout risks still hang over the story.Read more
